Current and prospective understanding of clinical classification, pathomechanisms and therapy in pemphigus

Archives of Dermatological Research, Supplement

Volumn 295, Issue 1, 2003, Pages

  Kitajima, Yasuo ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Pathomechanisms; Pemphigus

Indexed keywords

ANTIBODY; AUTOANTIBODY; DESMOGLEIN 1; DESMOGLEIN 1 ANTIBODY; DESMOGLEIN 3; DESMOGLEIN 3 ANTIBODY; IMMUNOGLOBULIN A; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; GLUCOCORTICOID; IMMUNOGLOBULIN G; PREDNISOLONE; STEROID;

ACANTHOLYSIS; ARTICLE; DESMOSOME; DISEASE CLASSIFICATION; DRUG INDUCED DISEASE; HERPETIFORM PEMPHIGUS; HUMAN; IMMUNOGLOBULIN A PEMPHIGUS; KERATINOCYTE; PARANEOPLASTIC PEMPHIGUS; PATHOPHYSIOLOGY; PEMPHIGUS; PEMPHIGUS FOLIACEUS; PEMPHIGUS VEGETANS; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; AUTOIMMUNE DISEASE; BLISTER; DERMIS; DRUG INDUCED PEMPHIGUS; EPIDERMIS; EROSION; PATHOGENESIS;

EID: 0037622122     PISSN: 09441948     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-002-0368-1     Document Type: Article

References (50)

1. Stanley JR (1992) Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid, bullous diseases due to defective epidermal cell adhesion. Adv Immunol 53:291-325
2. Kitajima Y, Aoyama Y, Seishima M (1999) Transmembrane signaling for adhesive regulation of desmosomes and hemidesmosomes, and for cell-cell detachment induced by pemphigus IgG in cultured keratinocytes: involvement of protein kinase C. J Investig Dermatol Symp Proc 4:137-144
3. Amagai M (1999) Autoimmunity against desmosomal cadherins in pemphigus. J Dermatol Sci 20:92-102
4. Amagai M, Komai A, Hashimoto T, et al (1999) Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus. Br J Dermatol 140:351-357
5. Ishii K, Amagai M, Hall RP, et al (1997) Characterization of autoantibodies in pemphigus using antigen-specific ELISAs with baculovirus expressed recombinant desmogleins. J Immunol 159:2010-2017
6. Hashimoto T (1999) Skin diseases related to abnormality in desmosomes and hemidesmosomes (editorial review). J Dermatol Sci 20:81-84
7. Nojiri M, Seishima M, Hirose M, et al (1996) Immunofluorescence and immunoblot studies of herpetiform pemphigus. Eur J Dermatol 6:406-408
8. Ishii K, Amagai M, Komai A, et al (1999) Desmoglein 1 and desmoglein 3 are the target autoantigens in herpetiform pemphigus. Arch Dermatol 135:943-947
9. O'Toole EA, Mak LL, Guitart J, et al (2000) Induction of keratinocyte interleukin-8 expression and secretion by IgG autoantibodies as a novel mechanism of epidermal neutrophil recruitment in a pemphigus variant. Clin Exp Immunol 119:217-224
10. Futei Y, Amagai M, Sekiguchi M, et al (2000) Use of domain-swapped molecules for conformational epitope mapping of desmoglein 3 in pemphigus vulgaris. J Invest Dermatol 115:829-834
11. Kalish RS (2000) Pemphigus vulgaris: the other half of the story. J Clin Invest 106:1433-1435
12. Nguyen VT, Lee TX, Ndoye A, et al (1998) The pathophysiological significance of nondesmoglein targets of pemphigus autoimmunity. Development of antibodies against keratinocyte cholinergic receptors in patients with pemphigus vulgaris and pemphigus foliaceus. Arch Dermatol 134:971-980
13. Nguyen VT, Ndoye A, Shultz LD, et al (2000) Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions. J Clin Invest 106:1467-1479
14. Nguyen VT, Ndoye A, Grando SA (2000) Pemphigus vulgaris antibody identifies pemphaxin, a novel keratinocyte annexin-like molecule binding acetylcholine. J Biol Chem 275:29466-29476
15. Anhalt GJ, Labib RS, Voorhees JJ, et al (1982) Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med 306:1189-1196
16. Amagai M, Karpati S, Prussick R, et al (1992) Autoantibodies against the aminoterminal cadherin-like bonding domain of pemphigus vulgaris antigen are pathogenic. J Clin Invest 90:919-926
17. Amagai M, Hashimoto T, Shimizu N, et al (1994) Absorption of pathogenic auto-antibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by the baculovirus. J Clin Invest 94:59-67
18. Ding X, Diaz LA, Fairley JA, et al (1999) The anti-desmoglein 1 autoantibodies in pemphigus vulgaris sera are pathogenic. J Invest Dermatol 112:739-743
19. Mahoney MG, Wang Z, Rothenberger K, et al (1999) Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest 103:461-468
20. Stanley JR (2000) The pathophysiology of pemphigus. J Dermatol Sci 24:155-157
21. Sergei AG (2000) Autoimmunity to keratinocyte acetylcholine receptors in pemphigus. Dermatology 201:290-295
22. Koch PJ, Mahoney MG, Ishikawa H, et al (1997) Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J Cell Biol 137:1091-1102
23. Amagai M, Matsuyoshi N, Wang ZH, et al (2000) Toxin in bullous impetigo and staphylococcal scaled-skin syndrome targets desmoglein 1. Nat Med 6:1275-1277
24. Sato M, Aoyama Y, Kitajima Y (2000) Assembly pathway pf desmoglein 3 to desmosomes and its perturbation by pemphigus vulgaris-IgG in cultured keratinocytes, as revealed by time-lapsed labeling immunoelectron microscopy. Lab Invest 80:1583-1592
25. ++ concentration. J Invest Dermatol 89:167-171
26. Kitajima Y, Tsujimura Y, Sato M, et al (2001) Evidence that pemphigus vulgaris IgG causes no steric hindrance in desmosome formation, but forms desmoglein 3-deficient desmosomes (abstract). J Invest Dermatol 117:406
27. Aoyama Y, Kitajima Y (1999) Pemphigus vulgaris-IgG causes a rapid depletion of desmoglein 3 (Dsg3) from the Triton X-100 soluble pools, leading to the formation of Dsg3-depleted desmosomes in a human squamous carcinoma cell line, DJM-1 cells. J Invest Dermatol 112:67-71
28. Aoyama Y, Owada MK, Kitajima Y (1999) A pathogenic autoantibody, pemphigus IgG, induces phosphorylation of desmoglein 3, and its dissociation from plakoglobin in cultured keratinocytes. Eur J Immunol 29:2233-2240
29. Caldelari R, de Bruin A, Boumann D, et al (2001) A central role for the armadillo protein plakoglobin in the autoimmune disease pemphigus vulgaris. J Cell Biol 153:823-834
30. Seishima M, Esaki C, Osada K, et al (1995) Pemphigus IgG, but not bullous pemphigoid IgG, causes a transient increase in intracellular calcium and inositol 1,4,5-trisphosphate in DJM-1 cells, a squamous cell carcinoma line. J Invest Dermatol 104:33-37
31. Esaki C, Seishima M, Yamada T, et al (1995) Pharmacologic evidence for involvement of phospholipase C in pemphigus IgG-induced inositol 1,4,5-trisphosphate generation, intracellular calcium increase, and plasminogen activator secretion in DJM-1 cells, a squamous cell carcinoma line. J Invest Dermatol 105:329-333
32. Seishima M, Iwasaki-Bessho Y, Itoh Y, et al (1999) Phosphatidylcholine-specific phospholipase C, but not phospholipase D, is involved in pemphigus IgG-induced signal transduction. Arch Dermatol Res 291:606-613
33. Osada K, Seishima M, Kitajima Y (1997) Pemphigus IgG activates and translocates protein kinase C from the cytosol to the particulate/cytoskeleton fractions in human keratinocytes. J Invest Dermatol 108:482-487
34. Kowalewski C, Mackiewicz W, Schmitt D, et al (2001) Cell-cell junctions in acantholytic diseases: junction proteins in nonimmune and autoimmune acantholysis. Arch Dermatol Res 293:1-11
35. Hashimoto K, Shafran KM, Webber PA, et al (1983) Anti-cell surface pemphigus antibody stimulates plasminogen activator activity of human epidermal cells. A mechanism for the loss of epidermal cohesion and blister formation. J Exp Med 157:259-272
36. Morioka S, Naito K, Ogawa H (1981) The pathogenic role of pemphigus antibodies and proteinase in epidermal acantholysis. J Invest Dermatol 76:337-341
37. Singer KH, Sawka NJ, Samowitz HR, et al (1980) activation: a mechanism for cellular dyshesion in pemphigus. J Invest Dermatol 74:363-367
38. Hashimoto K, Wun TC, Baird J, et al (1989) Characterization of keratinocyte plasminogen activator inhibitors and demonstration of the prevention of pemphigus IgG-induced acantholysis by a purified plasminogen activator inhibitor. J Invest Dermatol 92:310-314
39. Wilkinson JE, Smith CA, Suter MM, et al (1989) Role of plasminogen activator in pemphigus vulgaris. Am J Pathol 134:561-569
40. Seishima M, Satoh S, Nojiri M, et al (1997) Pemphigus IgG induces expression of urokinase plasminogen activator receptor on the cell surface of cultured keratinocytes. J Invest Dermatol 109:650-655
41. Overton J (1968) The fate of desmosomes in trypsinized tissue. J Exp Zool 168:203-214
42. Takahashi Y, Patel HP, Labib RS, et al (1985) Experimentally induced pemphigus vulgaris in neonatal BALB/c mice: a time-course study of clinical, immunologic, ultrastructural, and cytochemical changes. J Invest Dermatol 84:41-46
43. Iwatsuki K, Takigawa M, Imaizumi S, et al (1989) In vivo binding site of pemphigus vulgaris antibodies and their fate during acantholysis. J Am Acad Dermatol 20:578-582
44. Karpati S, Amagai M, Prussick R, et al (1993) Pemphigus vulgaris antigen, a desmoglein type of cadherin, is localized within keratinocyte desmosomes. J Cell Biol 122:409-415
45. Futamura S, Martins C, Rivitti EA, et al (1989) Ultrastructural studies of acantholysis induced in vivo by passive transfer of IgG from endemic pemphigus foliaceus (Fogo Selvagem). J Invest Dermatol 93:480-485
46. Masonry MG, Wang ZH, Stanley JR (1999) Pemphigus vulgaris and pemphigus foliaceus antibodies are pathogenic in plasminogen activator knockout mice. J Invest Dermatol 113:22-25
47. Aoyama Y, Tsujimura Y, Funabashi M, et al (2000) An experience for ELISA for desmoglein 1, suggesting a possible diagnostic help to determine the initial therapy for pemphigus foliaceus. Eur J Dermatol 10:18-21
48. Lin MS, Swartz SJ, Lopez A, et al (1997) Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris. J Clin Invest 99:31-40
49. Hertl M, Amagai M, Sundaram H, et al (1998) Recognition of desmoglein 3 by autoreactive T cells in pemphigus vulgaris patients and normals. J Invest Dermatol 110:62-66
50. Proby CM, Ota T, Suzuki H, et al (2000) Development of chimeric molecules for recognition and targeting of antigen-specific B cells in pemphigus vulgaris. Br J Dermatol 142:321-330